Vera Gibb
The Need for Routine Migraine Screening in Women’s Health Care
Migraine Is Common, Disabling, and Often Overlooked Migraine is the second leading cause of disability worldwide and the leading cause among women under 50. It affects...
Clinical Recommendations for Managing Menstrual Migraine
Menstrual migraine (MM) affects 20–25% of women with migraine and accounts for 22–70% of patients in specialized headache centers.1 For a healthcare provider, migraine attacks that...
Addressing Medication Overuse Headache (MOH) in Clinical Practice
Medication overuse headache (MOH), formerly known as rebound headache, is a prevalent and disabling headache disorder commonly encountered in clinical practice. Globally, more than 60 million...
American Headache Society Position Statement: Calcitonin Gene-Related Peptide (CGRP) Inhibitors should now be considered a first-line option for migraine prevention
Calcitonin gene-related peptide (CGRP) inhibitors are the first drugs developed for migraine prevention. All other agents used to prevent migraine prior to 2018, were originally developed...
How to Utilize Available Community Resources and Support Services to Help Headache Patients
Headache disorders are an invisible epidemic. Nearly 90% of the US population has experienced some type of head pain such as tension-type headaches, migraine attacks, cluster...
How to Get Prior Authorizations for Migraine Medications Approved
Celebrities such as Kristin Chenoweth, Whoopi Goldberg, Hugh Jackman, Serena Williams, Ben Affleck, Virginia Madsen, Lady Gaga, Lisa Kudrow, Jennifer Morrison, James Cromwell, Khloe Kardashian, Whitney...
The Importance of Asking About Adverse Childhood Experiences in People Living With Migraine
Migraine is a chronic neuroinflammatory disorder that occurs across the lifespan with episodic exacerbations and age-dependent changes in clinical presentations/prevalence.1 Early life stress and adverse childhood...
